To further assess the involvement of Loxl3 in melanoma progression in an immunoproficient setting, we used the highly metastatic B16-F10 mouse melanoma cell line, which can be transplanted into syngeneic C57BL/6 mice [48]. Here, LOXL3 is linked to melanoma.